| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |